Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUtil Regulatory News (UTL)

Share Price Information for Util (UTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 101.00
Ask: 106.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.95%)
Open: 103.50
High: 103.50
Low: 103.50
Prev. Close: 103.50
UTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of monthly factsheet

18 May 2022 09:45

RNS Number : 9386L
UIL Limited
18 May 2022
 

18 May 2022

 

UIL LIMITED

(LEI Number: 213800CTZ7TEIE7YM468)

 

Publication of monthly factsheet

 

The latest monthly factsheet for UIL Limited ("UIL" or the "Company") will shortly be available through the Company's website at:

https://www.uil.limited/investor-relations/factsheet-archive

 

Monthly commentary

 

PERFORMANCE

UIL's NAV total return decreased by 3.0% in April, underperforming the FTSE All Share total return Index which was up marginally by 0.3% over the month.

 

Markets in April remained volatile, still affected by the Russian war with Ukraine which endures will little resolution on the horizon and with energy supplies tightening as Russia halted gas supplies to Poland and Bulgaria, with both countries refusing to pay in Roubles as decreed by Russia. The ongoing lockdowns in China further added to the pressure on the already disrupted global supply chain, as the country persists with its zero-Covid-19 policy, also heightening concern on what the impact will be on the global economy. In addition, the weaker economic data emerging from the US was discouraging whilst inflationary pressures persisted resulting in Jerome Powell, chairman of the Federal Reserve indicating a more aggressive path of interest rate increases is on the horizon. President Emmanuel Macron was also re-elected for his second term in April as the French President; however, his victory was overshadowed by the fact that Marine Le Pen won more votes that any far-right candidate in the history of the French Republic.

 

Markets in April were mostly down. The S&P Index was down by 8.8%, the Eurostoxx down 2.6% and the Dax Index down by 2.2%. The emerging markets Indices fared worse, with the Brazilian Bovespa down by 10.1%, the Mexican Bolsa down by 9.1% and the Chinese Shanghai Composite down 6.3%. The FTSE 100 Index managed to buck the trend ending the month up 0.4% despite the UK economy slowing more than expected and inflation continuing to edge higher with the consumer price index hitting its highest level since 1992 at 7.0%.

 

The weaker UK data resulted in Sterling performing poorly in the month of April, depreciating against most currencies, down 4.6% against the US Dollar (partially due to the strong performance of the US Dollar), down 4.5% against the Hong Kong Dollar and down 3.8% against the Indian Rupee. Sterling did strengthen marginally in April against the Australian Dollar by 0.8% and by 2.2% against the New Zealand Dollar.

 

The Brent Crude oil price continued to benefit over the month, up by 1.3% to USD 109.34/bbl on the back of ongoing concerns around energy supplies due to the geopolitical issues with Russia, whilst industrial metal prices such as copper fell 7.5% on the back of concerns prompted by slower economic growth and Covid-19 lockdowns in China. Gold was also down in April by 2.1% to USD 1,896.93/oz.

 

PORTFOLIO

There were no changes to UIL's top ten constitutes in April.

 

One of the top performers for the month was Resolute Mining, up 6.1% on the back of its quarterly activities report which reported a reduction in net debt by USD 54.1m due to improved operational performance and asset sales of USD 43.7m.

 

Orbital's shares remain volatile and its share price decreased by 22.9% during the period after gaining 59.1% in March. Somers' valuation declined by 7.0%, primarily due to the 7.4% decrease in Resimac's share price, its largest holding. Starpharma's share price was down 6.1% and Allectus' valuation was down 1.1%.

 

Purchases during the month for the portfolio totalled £6.2m and realisations amounted to £2.7m.

 

DEBT

Bank debt positions were slightly reduced in underlying foreign currency terms in April, though Sterling's weakness resulted in the overall liability increasing marginally to £51.8m from £51.4m. The facility was drawn as AUD 34.1m, USD 29.7m and EUR 10.6m.

 

Foreign exchange hedge positions as at the end of April against Sterling were AUD 64.6m, CAD 61.8m, USD 61.3m and EUR 9.0m. The AUD hedge against USD was unchanged at AUD 10.0m. 

 

OTHER

UIL's ordinary share price decreased by 0.8% to 238.00p. The discount to NAV narrowed to 33.7% as at 30 April 2022 from 35.1% as at 31 March 2022.

 

The share prices of the 2022 and 2024 ZDP shares were unchanged and the share prices of the 2026 and 2028 ZDP shares increased by 1.3% and 2.6%, respectively.

 

 

Name of contact and telephone number for enquiries:

 

Charles Jillings

ICM Investment Management Limited and ICM Limited

Telephone: 01372 271486

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCSFESAAEESELI
Date   Source Headline
14th Jun 202410:45 amRNSNet Asset Value(s)
13th Jun 202412:14 pmRNSNet Asset Value(s)
12th Jun 202410:34 amRNSNet Asset Value(s)
11th Jun 202412:01 pmRNSNet Asset Value(s)
10th Jun 202411:51 amRNSNet Asset Value(s)
7th Jun 202412:22 pmRNSNet Asset Value(s)
6th Jun 202411:16 amRNSNet Asset Value(s)
5th Jun 202411:34 amRNSNet Asset Value(s)
4th Jun 202411:38 amRNSNet Asset Value(s)
3rd Jun 202411:37 amRNSNet Asset Value(s)
31st May 202412:06 pmRNSNet Asset Value(s)
30th May 202410:54 amRNSNet Asset Value(s)
29th May 202412:17 pmRNSNet Asset Value(s)
28th May 202411:15 amRNSNet Asset Value(s)
24th May 202411:56 amRNSNet Asset Value(s)
23rd May 202412:14 pmRNSNet Asset Value(s)
22nd May 202412:27 pmRNSNet Asset Value(s)
21st May 202411:43 amRNSNet Asset Value(s)
20th May 202412:18 pmRNSNet Asset Value(s)
17th May 202412:06 pmRNSNet Asset Value(s)
16th May 202411:36 amRNSNet Asset Value(s)
15th May 20244:31 pmRNSPublication of monthly factsheet
15th May 202412:11 pmRNSNet Asset Value(s)
14th May 202411:23 amRNSNet Asset Value(s)
13th May 202412:26 pmRNSNet Asset Value(s)
10th May 202412:23 pmRNSNet Asset Value(s)
9th May 202412:16 pmRNSNet Asset Value(s)
8th May 202412:23 pmRNSNet Asset Value(s)
8th May 202412:18 pmRNSQ2 2023/24 dividend - revised payment date
7th May 202411:46 amRNSNet Asset Value(s)
3rd May 202412:30 pmRNSNet Asset Value(s)
2nd May 202412:01 pmRNSNet Asset Value(s)
1st May 202411:52 amRNSNet Asset Value(s)
30th Apr 202412:17 pmRNSNet Asset Value(s)
29th Apr 202411:44 amRNSNet Asset Value(s)
26th Apr 202412:11 pmRNSNet Asset Value(s)
25th Apr 202412:17 pmRNSNet Asset Value(s)
24th Apr 202412:03 pmRNSNet Asset Value(s)
23rd Apr 202411:18 amRNSNet Asset Value(s)
22nd Apr 202411:22 amRNSNet Asset Value(s)
19th Apr 202411:34 amRNSNet Asset Value(s)
18th Apr 202411:04 amRNSNet Asset Value(s)
17th Apr 202411:40 amRNSNet Asset Value(s)
16th Apr 202411:27 amRNSNet Asset Value(s)
15th Apr 202412:18 pmRNSNet Asset Value(s)
12th Apr 20241:40 pmRNSPublication of monthly factsheet
12th Apr 202412:27 pmRNSNet Asset Value(s)
11th Apr 202412:20 pmRNSNet Asset Value(s)
10th Apr 202412:49 pmRNSNet Asset Value(s)
9th Apr 202412:01 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.